for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CORRECTED-AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJ

(Corrects to say person familiar with the matter, not people, in paragraph 1)

Oct 23 (Reuters) - Federal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing a person familiar with the matter. (Reporting by Munsif Vengattil; Editing by Maju Samuel)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up